RACHAEL ROMER: Open Payments
NPI 1861009599 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 17 payments from 5 companies in 2025. Trend: 2023 $315 · 2024 $27 · 2025 $365
Food & beverage: $349Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $239 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: Wegovy, Ozempic, PAXLOVID, VRAYLAR, SHINGRIX, OTEZLA, REPATHA, Rybelsus.
Industry payments across NJ — which companies pay providers there.
